DealsJun 10, 2026, 06:06 AM
VolitionRx Prices $4.6M Public Offering with Warrants
AI Summary
VolitionRx Limited announced the pricing of its public offering, selling 2,960,000 shares of common stock along with warrants to purchase an additional 1,480,000 shares. The combined offering price was $1.55 per share and accompanying warrant, resulting in approximately $4.1 million in net proceeds. The company plans to use these funds for research, product development, clinical studies, commercialization, working capital, and repayment of convertible notes. Maxim Group LLC served as the sole placement agent.
Key Highlights
- VolitionRx priced a public offering of 2,960,000 shares and warrants to purchase 1,480,000 shares.
- The combined offering price was $1.55 per share and accompanying warrant.
- The offering generated approximately $4.1 million in net proceeds for VolitionRx.
- Additional gross proceeds of approximately $2.3 million could be raised if warrants are fully exercised.
- Proceeds are intended for research, product development, clinical studies, commercialization, and working capital.
- Maxim Group LLC acted as the sole placement agent for the offering.
Price Impact
More from VNRX